Up to $2.5 million in funding from NIH will be used to develop TIMING™ kits for manufacturing analytics that provide end-users with rapid, specific and predictive results to accelerate translational research and the development and manufacture of more effective cell therapies to benefit patients
HOUSTON, Texas — May 2, 2024. CellChorus®, the dynamic single-cell analysis company™, announced that the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) has awarded CellChorus a Small Business Innovation Research (SBIR) Fast-Track grant to advance the development of its Time-lapse Imaging Microscopy In Nanowell Grids™ (TIMING™) platform for dynamic single-cell analysis. A two-year $2.1 million Phase II grant will begin after predetermined milestones are achieved under a $350,000 Phase I grant that is underway.
